ClinicalTrials.Veeva

Menu
U

University Hospital in Krakow | Neurology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Empagliflozin
Pacritinib
Gabapentin
BI456906
Dabigatran Etexilate
Methylprednisolone
BI 765845

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 8 total trials
Locations recently updated

A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis (PACIFICA)

This study (study ID PAC203 North America; PAC303 ex-North America) is evaluating 200 mg BID of pacritinib compared to physician's choice (P/C) thera...

Enrolling
Post-essential Thrombocythemia Myelofibrosis
Post-polycythemia Vera Myelofibrosis
Drug: Physician's Choice medications
Drug: Pacritinib

This study is open to adults aged 18 and over who have just had a heart attack. The purpose of this study is to find out whether a medicine called BI...

Active, not recruiting
Myocardial Infarction
Drug: BI 765845
Drug: Placebo matching BI 765845

Trial sponsors

Boehringer Ingelheim logo
Sobi logo
J
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems